Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
CAMA-1
HR+
Luminal
Ixabepilone
TUBB
TUBB
5911.094
uM
0.00116
0.00147
-0.9872 -0.4078 2.5090 1.3193
0.6376
1.0146
ZR75B
HR+
Luminal
Torkinib
15405.211
uM
0.00030
0.00154
-0.3164 -0.3506 0.3246 0.9816
0.9922
1.5333
HBL-100
Unknown
Unknown
Docetaxel
TUBB
TUBB
7808.002
uM
0.00194
0.00155
0.3152 0.1983 2.2864 0.5513
0.9438
2.3302
MDA-MB-436
TNBC
Basal B
Geldanamycin
HSP90
HSP90
7900.012
uM
0.00157
0.00156
-0.2721 0.0157 5.0000 0.8700
0.6184
0.8090
HCC2185
TNBC
Luminal
Sirolimus
MTOR
MTOR
7845.068
uM
0.00087
0.00157
-0.5451 -0.3982 0.9850 1.2168
0.9289
0.3849
SUM159PT
TNBC
Basal B
Docetaxel
TUBB
TUBB
13004.002
uM
0.00146
0.00162
-0.0693 -0.0843 1.4851 0.7365
0.9961
3.1387
HCC1569
HER2amp
Basal A
Docetaxel
TUBB
TUBB
9347.002
uM
inf
0.00163
0.5098 0.5087 1.2928 0.3277
0.9210
1.4904
184A1
NM
Basal
Docetaxel
TUBB
TUBB
9047.002
uM
0.00721
0.00164
0.3271 0.2689 0.5211 0.4844
0.7111
0.5243
MCF 10A
NM
Basal B
Dichloroacetate
PDK
PDK
12944.176
uM
inf
0.00165
0.9070 0.9353 1.3443 0.0350
0.7319
2.5862
SUM225CWN
HER2amp
Basal A
Sirolimus
MTOR
MTOR
7533.069
uM
0.00404
0.00166
0.2934 0.3132 1.1071 0.5248
0.9943
1.1713
BT-474
HER2amp
Luminal
Ixabepilone
TUBB
TUBB
5906.095
uM
0.00127
0.00167
-0.9990 -0.3324 1.8966 0.9953
0.6890
0.6731
HCC1187
TNBC
Basal A
Bortezomib
Proteasome
Proteasome
15300.203
uM
0.00104
0.00168
-0.9901 -0.9929 2.2895 1.6434
0.9968
0.8443
HCC1187
TNBC
Basal A
Bortezomib
Proteasome
Proteasome
15300.203
uM
0.00104
0.00168
-0.9901 -0.9929 2.2895 1.6434
0.9968
0.8443
HCC1806
TNBC
Basal A
Docetaxel
TUBB
TUBB
12702.002
uM
0.00118
0.00171
-0.4526 -0.4961 1.8445 1.0089
0.9954
1.8712
HCC1395
TNBC
Basal B
GSK461364
PLK1
PLK
7816.001
uM
0.00151
0.00173
-0.9805 -0.4672 4.9998 1.1061
0.9094
1.0243
SUM52PE
HR+
Luminal
Docetaxel
TUBB
TUBB
9889.002
uM
0.00130
0.00174
-0.3619 -0.3400 1.7739 0.9146
0.9936
1.1879
MDA-MB-361
HER2amp
Luminal
GSK461364
PLK1
PLK
7894.001
uM
0.00171
0.00176
-0.2941 -0.0655 5.0000 0.8182
0.9150
0.7678
SK-BR-3
HER2amp
Luminal
Trastuzumab
HER2
ErbB
9760.026
uM
inf
0.00176
0.5020 0.5240 4.9999 0.3121
0.9733
1.0724
HCC38
TNBC
Basal B
Topotecan
TOP1
TOP
9469.121
uM
0.00096
0.00177
-0.7010 -0.7334 1.4902 1.4796
0.9951
1.1298
HBL-100
Unknown
Unknown
Docetaxel
TUBB
TUBB
7807.002
uM
0.00197
0.00179
0.2403 0.1261 3.1066 0.6084
0.9293
2.1668
SUM149PT
TNBC
Basal B
Docetaxel
TUBB
TUBB
9830.002
uM
0.00179
0.00180
-0.0390 -0.0047 2.1102 0.6781
0.950
1.9252
HCC1569
HER2amp
Basal A
Trastuzumab
HER2
ErbB
7447.102
uM
inf
0.00181
0.7277 0.8106 1.1886 0.1183
0.8186
1.6467
AU565
HER2amp
Luminal
Trastuzumab
HER2
ErbB
9146.122
uM
inf
0.00184
0.5003 0.6442 5.0000 0.2137
0.8848
1.3408
MDA-MB-175-VII
HR+
Luminal
Sirolimus
MTOR
MTOR
7500.069
uM
0.00293
0.00185
0.3935 0.4499 4.9999 0.4145
0.9762
0.7701
HCC1569
HER2amp
Basal A
Sirolimus
MTOR
MTOR
7447.068
uM
0.01777
0.00189
0.2985 0.3535 0.5478 0.5385
0.9617
1.5836